Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Equities research analysts at KeyCorp lowered their FY2018 earnings estimates for shares of Acadia Healthcare in a report released on Wednesday, Zacks Investment Research reports. KeyCorp analyst J. Gurda now anticipates that the company will post earnings per share of $2.46 for the year, down from their prior estimate of $2.84. KeyCorp currently has a “Buy” rating and a $59.00 target price on the stock. KeyCorp also issued estimates for Acadia Healthcare’s FY2019 earnings at $2.73 EPS.
Other analysts have also recently issued reports about the stock. Cantor Fitzgerald lowered their price objective on shares of Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating for the company in a research note on Tuesday, October 24th. Mizuho boosted their price objective on shares of Acadia Healthcare from $57.00 to $60.00 and gave the company a “buy” rating in a research note on Friday, July 28th. Deutsche Bank AG boosted their price objective on shares of Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, July 31st. Craig Hallum reissued a “buy” rating and set a $65.00 price objective (up from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Finally, UBS AG reissued a “positive” rating and set a $60.00 price objective (up from $54.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Two analysts have rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the company’s stock. Acadia Healthcare presently has a consensus rating of “Hold” and a consensus price target of $45.15.
COPYRIGHT VIOLATION NOTICE: This news story was originally published by Week Herald and is owned by of Week Herald. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://weekherald.com/2017/11/15/acadia-healthcare-company-inc-achc-expected-to-post-fy2018-earnings-of-2-46-per-share.html.
Shares of Acadia Healthcare (NASDAQ ACHC) traded up $0.19 during midday trading on Monday, hitting $28.42. 1,009,100 shares of the stock traded hands, compared to its average volume of 1,342,921. Acadia Healthcare has a one year low of $27.56 and a one year high of $54.34. The stock has a market cap of $2,480.11, a PE ratio of 12.33, a PEG ratio of 1.05 and a beta of 0.89. The company has a debt-to-equity ratio of 1.30, a current ratio of 1.36 and a quick ratio of 1.36.
Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The business had revenue of $716.70 million during the quarter, compared to analyst estimates of $728.86 million. During the same quarter last year, the firm posted $0.58 earnings per share. The company’s revenue was down 2.4% on a year-over-year basis.
A number of large investors have recently bought and sold shares of ACHC. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Acadia Healthcare by 11.1% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after buying an additional 270 shares during the last quarter. C M Bidwell & Associates Ltd. purchased a new position in Acadia Healthcare in the 2nd quarter valued at about $205,000. Riverhead Capital Management LLC purchased a new position in Acadia Healthcare in the 2nd quarter valued at about $209,000. Paloma Partners Management Co purchased a new position in Acadia Healthcare in the 1st quarter valued at about $217,000. Finally, Rathbone Brothers plc purchased a new position in Acadia Healthcare in the 3rd quarter valued at about $223,000.
In other Acadia Healthcare news, EVP Christopher L. Howard sold 53,713 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $2,722,711.97. Following the completion of the transaction, the executive vice president now directly owns 147,286 shares of the company’s stock, valued at approximately $7,465,927.34. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, President Brent Turner sold 206,252 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the completion of the transaction, the president now directly owns 81,106 shares of the company’s stock, valued at $4,111,263.14. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,824,040 shares of company stock valued at $92,460,588. 11.10% of the stock is currently owned by corporate insiders.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.